Robert A Dimella sold $11 of MMD
other at NYLI MacKay DefinedTerm Muni Opportunities Fund. 1 shares at an average of $14.92, traded Nov 25, 2025, filed Dec 1, 2025.
Score components
- +8RoleOther
- 0Trade size$11 at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000945621-25-001163, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2025 | SOpen-market sale Shares of beneficial interest | -1 | $14.92 | $11 | 0 | Dec 1, 2025 |
Related signals
Other insiders at NYLI MacKay DefinedTerm Muni Opportunities Fund and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | MMDsell NYLI MacKay DefinedTerm Muni Opportunities Fund | Robert A Dimella other | $178k 11,965 shares | -100% | |
| 23Weak | MMDbuy NYLI MacKay DefinedTerm Muni Opportunities Fund | David Dowden other | $49k 3,300 shares | - | |
| 22Weak | MMDbuy NYLI MacKay DefinedTerm Muni Opportunities Fund | John J Lawlor other | $39k 2,500 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.